AZ3391 |
Catalog No.GC65899 |
AZ3391 es un potente inhibidor de PARP. AZ3391 es un derivado de la quinoxalina. La familia de enzimas PARP desempeÑa un papel importante en una serie de procesos celulares, como la replicaciÓn, la recombinaciÓn, la remodelaciÓn de la cromatina y la reparaciÓn del daÑo del ADN. AZ3391 tiene el potencial para la investigaciÓn de enfermedades y condiciones que ocurren en los tejidos del sistema nervioso central, como el cerebro y la médula espinal (extraÍdo de la patente WO2021260092A1, compuesto 23).
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2756333-42-1
Sample solution is provided at 25 µL, 10mM.
AZ3391 is a potent inhibitor of PARP. AZ3391 is a quinoxaline derivative. PARP family of enzymes play an important role in a number of cellular processes, such as replication, recombination, chromatin remodeling, and DNA damage repair. AZ3391 has the potential for the research of diseases and conditions occurring in tissues in the central nervous system, such as the brain and spinal cord (extracted from patent WO2021260092A1, compound 23)[1].
Average Rating: 5
(Based on Reviews and 30 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *